{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:06:42Z","timestamp":1791104802483,"version":"4.1.0"},"reference-count":87,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The diagnosis and classification of the cutaneous B-cell lymphomas can be quite a challenge, with a definitive diagnosis sometimes being elusive, even when an extensive workup has been performed. Distinction of benign from neoplastic disorders can be difficult, with some hyperplasias mimicking lymphomas and vice versa. There are only a limited number of skin-specific B-cell lymphomas, including primary cutaneous follicle center lymphoma and primary cutaneous diffuse large B-cell lymphoma, leg type. Cutaneous marginal zone lymphomas have distinctive features but are classified with the other mucosa-associated lymphoid tissue lymphomas. It is important, however, to also remember that many other B-cell lymphomas\/ plasma cell neoplasms can primarily, or more often secondarily, involve the skin. Some may mimic one of the skin-specific lymphomas but have very different clinical implications. Iatrogenic and senescent immunodeficiency-associated lymphoproliferative disorders that are often Epstein-Barr virus (EBV) positive can also primarily involve the skin, including cases also known as EBV-positive mucocutaneous ulcer.<\/jats:p>","DOI":"10.1309\/ajcpnlc9nc9wtqyy","type":"journal-article","created":{"date-parts":[[2013,3,22]],"date-time":"2013-03-22T22:42:35Z","timestamp":1363992155000},"page":"515-535","source":"Crossref","is-referenced-by-count":55,"title":["Cutaneous B-Cell Lymphoproliferative Disorders"],"prefix":"10.1093","volume":"139","author":[{"given":"Steven H.","family":"Swerdlow","sequence":"first","affiliation":[{"name":"1Department of Pathology, Division of Hematopathology, University of Pittsburgh School of Medicine, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Quintanilla-Martinez","sequence":"additional","affiliation":[{"name":"2Institute of Pathology, Eberhard-Karls-University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rein","family":"Willemze","sequence":"additional","affiliation":[{"name":"3Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marsha C.","family":"Kinney","sequence":"additional","affiliation":[{"name":"4Department of Pathology, University of Texas Health Science Center, San Antonio, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,4,1]]},"reference":[{"key":"2023012006304245700_b1-1390515","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1309\/AJCPX4BXTP2QBRKO","article-title":"Mimics of cutaneous lymphoma: report of the 2011 Society for Hematopathology\/ European Association for Haematopathology Workshop","volume":"139","author":"Sarantopoulos","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"2023012006304245700_b2-1390515","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/sder.2000.8329","article-title":"Cutaneous lymphoid hyperplasias","volume":"19","author":"Gilliam","year":"2000","journal-title":"Semin Cutan Med Surg"},{"key":"2023012006304245700_b3-1390515","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0046-8177(03)00075-3","article-title":"Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential","volume":"34","author":"Nihal","year":"2003","journal-title":"Hum Pathol"},{"key":"2023012006304245700_b4-1390515","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1309\/AJCP83AOQTMLOJTM","article-title":"Non\u2013 mycosis fungoides cutaneous T-cell lymphomas: Report of the 2011 Society for Hematopathology\/European Association for Haematopathology Workshop","volume":"139","author":"Quintanilla-Martinez","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"2023012006304245700_b5-1390515","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1097\/PAS.0b013e3180339f18","article-title":"Epstein-Barr virus negative clonal plasma cell proliferations and lymphomas in T-cell lymphomas: a phenomenon with distinctive clinicopathologic features","volume":"31","author":"Balague","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"2023012006304245700_b6-1390515","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood"},{"key":"2023012006304245700_b7-1390515","volume-title":"World Health Organization Classification of Tumors: Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001"},{"key":"2023012006304245700_b8-1390515","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"2023012006304245700_b9-1390515","volume-title":"Pathology and Genetics of Skin Tumours","author":"LeBoit","year":"2006"},{"key":"2023012006304245700_b10-1390515","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"2023012006304245700_b11-1390515","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","article-title":"Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases","volume":"113","author":"Bradford","year":"2009","journal-title":"Blood"},{"key":"2023012006304245700_b12-1390515","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/00000478-200005000-00008","article-title":"Clinicopathologic reassessment of primary cutaneous B-cell lymphomas with immunophenotypic and molecular genetic characterization","volume":"24","author":"Yang","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"2023012006304245700_b13-1390515","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/00000478-199410000-00001","article-title":"Primary cutaneous immunocytoma: a B-cell lymphoma that can easily be mistaken for cutaneous lymphoid hyperplasia","volume":"18","author":"LeBoit","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"2023012006304245700_b14-1390515","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00000478-199901000-00010","article-title":"Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features","volume":"23","author":"Baldassano","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"2023012006304245700_b15-1390515","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/00000478-199711000-00005","article-title":"Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma","volume":"21","author":"Cerroni","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"2023012006304245700_b16-1390515","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2340\/00015555-1112","article-title":"Survival data for 299 patients with primary cutaneous lymphomas: a monocentre study","volume":"91","author":"Hallermann","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"2023012006304245700_b17-1390515","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaad.2008.04.012","article-title":"Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and S\u00e9zary syndrome in primary cutaneous marginal zone lymphoma","volume":"59","author":"Gerami","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"2023012006304245700_b18-1390515","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/1523-1747.ep12614479","article-title":"Demonstration of clonal immunoglobulin gene rearrangements in cutaneous B-cell lymphomas and pseudo-B-cell lymphomas: differential diagnostic and pathogenetic aspects","volume":"99","author":"Rijlaarsdam","year":"1992","journal-title":"J Invest Dermatol"},{"key":"2023012006304245700_b19-1390515","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1600-0560.2011.01726.x","article-title":"Primary cutaneous marginal zone lymphoma with subclinical cutaneous involvement and biclonality","volume":"38","author":"Edinger","year":"2011","journal-title":"J Cutan Pathol"},{"key":"2023012006304245700_b20-1390515","first-page":"342","article-title":"Primary cutaneous marginal zone B-cell lymphoma with anetoderma: spontaneous involution plus de novo clonal expansion","volume":"38","author":"Ferrara","year":"2011","journal-title":"J Cutan Pathol"},{"key":"2023012006304245700_b21-1390515","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2141.2008.07159.x","article-title":"Results of bone marrow examination in 275 patients with histological features that suggest an indolent type of cutaneous B-cell lymphoma","volume":"142","author":"Senff","year":"2008","journal-title":"Br J Haematol"},{"key":"2023012006304245700_b22-1390515","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00000478-200106000-00004","article-title":"Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification","volume":"25","author":"de Leval","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"2023012006304245700_b23-1390515","first-page":"240A","article-title":"Cutaneous extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type: a multiparameter study, including molecular analyses for Borrelia burgdorferi DNA and AP12-MALT fusion transcripts [abstract]","volume":"16","author":"Kim","year":"2003","journal-title":"Mod Pathol"},{"key":"2023012006304245700_b24-1390515","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/DAD.0b013e31817d1391","article-title":"Is there a cutaneous variant of marginal zone hyperplasia?","volume":"30","author":"Guitart","year":"2008","journal-title":"Am J Dermatopathol"},{"key":"2023012006304245700_b25-1390515","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00000478-199501000-00002","article-title":"Cutaneous follicular lymphoid hyperplasia with monotypic plasma cells: a clinicopathologic study of 18 patients","volume":"19","author":"Schmid","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"2023012006304245700_b26-1390515","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1097\/PAS.0b013e3181f72835","article-title":"Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets","volume":"34","author":"Edinger","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"2023012006304245700_b27-1390515","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1309\/AJCP5W0VOCSVOBRA","article-title":"Cutaneous peripheral T-cell lymphoma associated with a proliferation of B cells","volume":"131","author":"Mattoch","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"2023012006304245700_b28-1390515","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1600-0560.2009.01408.x","article-title":"Multiple cutaneous monoclonal B-cell proliferations as harbingers of systemic angioimmunoblastic T-cell lymphoma","volume":"37","author":"Bayerl","year":"2010","journal-title":"J Cutan Pathol"},{"key":"2023012006304245700_b29-1390515","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/PAS.0b013e3181a6ae1e","article-title":"CD123-positive plasmacytoid dendritic cells in primary cutaneous marginal zone B-cell lymphoma: diagnostic and pathogenetic implications","volume":"33","author":"Kutzner","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"2023012006304245700_b30-1390515","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/00000478-200308000-00003","article-title":"Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathologic study of 24 Asian cases","volume":"27","author":"Li","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"2023012006304245700_b31-1390515","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"2023012006304245700_b32-1390515","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/00000478-200104000-00015","article-title":"Molecular genetic characterization of primary cutaneous B-cell lymphomas","volume":"25","author":"Child","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"2023012006304245700_b33-1390515","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/DAD.0b013e31818118f7","article-title":"Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates","volume":"30","author":"Morales","year":"2008","journal-title":"Am J Dermatopathol"},{"key":"2023012006304245700_b34-1390515","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaad.2009.12.062","article-title":"The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinical findings, histology, and immunohistochemistry","volume":"64","author":"Felcht","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"2023012006304245700_b35-1390515","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1034\/j.1600-0560.2002.290306.x","article-title":"Heavy multinodular cutaneous lymphoid infiltrates: clinicopathologic features and B-cell clonality","volume":"29","author":"Ceballos","year":"2002","journal-title":"J Cutan Pathol"},{"key":"2023012006304245700_b36-1390515","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/sj.leu.2404479","article-title":"Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets: report of the BIOMED-2 Concerted Action BHM4-CT98-3936","volume":"21","author":"Evans","year":"2007","journal-title":"Leukemia"},{"key":"2023012006304245700_b37-1390515","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.0303-6987.2006.00459.x","article-title":"t(14;18)(q32;q21) involving IGH and MALT1 is uncommon in cutaneous MALT lymphomas and primary cutaneous diffuse large B-cell lymphomas","volume":"33","author":"Wongchaowart","year":"2006","journal-title":"J Cutan Pathol"},{"key":"2023012006304245700_b38-1390515","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.humpath.2006.02.012","article-title":"Aberrant nuclear BCL10 expression and lack of t(11;18)(q21;q21) in primary cutaneous marginal zone B-cell lymphoma","volume":"37","author":"Gallardo","year":"2006","journal-title":"Hum Pathol"},{"key":"2023012006304245700_b39-1390515","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/modpathol.2008.159","article-title":"Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathological study of cases from Asia, Germany, and the United States","volume":"21","author":"Takino","year":"2008","journal-title":"Mod Pathol"},{"key":"2023012006304245700_b40-1390515","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1182\/blood-2008-01-132415","article-title":"The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment","volume":"112","author":"van Maldegem","year":"2008","journal-title":"Blood"},{"key":"2023012006304245700_b41-1390515","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2559.1993.tb00469.x","article-title":"Cutaneous immunocytomas: a clinicopathologic study of 26 cases","volume":"23","author":"Rijlaarsdam","year":"1993","journal-title":"Histopathology"},{"key":"2023012006304245700_b42-1390515","first-page":"204","article-title":"Cutaneous involvement in primary extracutaneous B-cell lymphoma","volume-title":"World Health Organization Classification of Tumours: Pathology & Genetics: Skin Tumours","author":"Swerdlow","year":"2006"},{"key":"2023012006304245700_b43-1390515","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1097\/PAS.0b013e3181b201de","article-title":"IgG4-related sclerosing disease: a potential new etiology of cutaneous pseudolymphoma","volume":"33","author":"Cheuk","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"2023012006304245700_b44-1390515","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.humpath.2009.01.013","article-title":"High ratio of IgG4-positive plasma cell infiltration in cutaneous plasmacytosis: is this a cutaneous manifestation of IgG4-related disease?","volume":"40","author":"Miyagawa-Hayashino","year":"2009","journal-title":"Hum Pathol"},{"key":"2023012006304245700_b45-1390515","first-page":"227","article-title":"Primary cutaneous follicle centre lymphoma","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Willemze","year":"2008"},{"key":"2023012006304245700_b46-1390515","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jaad.2010.06.059","article-title":"Clinicopathologic features of early lesions of primary cutaneous follicle center lymphoma, diffuse type: implications for early diagnosis and treatment","volume":"65","author":"Gulia","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"2023012006304245700_b47-1390515","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaad.2010.07.035","article-title":"Miliary and agminated-type primary cutaneous follicle center lymphoma: report of 18 cases","volume":"65","author":"Massone","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"2023012006304245700_b48-1390515","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","article-title":"Reclassification of 300 primary cutaneous B-cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers","volume":"25","author":"Senff","year":"2007","journal-title":"J Clin Oncol"},{"key":"2023012006304245700_b49-1390515","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood-2008-04-152850","article-title":"European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas","volume":"112","author":"Senff","year":"2008","journal-title":"Blood"},{"key":"2023012006304245700_b50-1390515","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.pas.0000146015.22624.c7","article-title":"Clinicopathologic, immunophenotypic, and molecular cytogenetic fluorescence in situ hybridization analysis of primary and secondary cutaneous follicular lymphomas","volume":"29","author":"Kim","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"2023012006304245700_b51-1390515","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/1066896908323097","article-title":"B-cell cutaneous lymphoid hyperplasia representing progressive transformation of germinal center: a report of 2 cases","volume":"18","author":"Kojima","year":"2010","journal-title":"Int J Surg Pathol"},{"key":"2023012006304245700_b52-1390515","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/DAD.0b013e318255dbae","article-title":"Clonal identity and differences in primary cutaneous B-cell lymphoma occurring at different sites or time points in the same patient","volume":"35","author":"Fujiwara","year":"2013","journal-title":"Am J Dermatopathol"},{"key":"2023012006304245700_b53-1390515","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/PAS.0b013e3181e5060a","article-title":"IgM expression on paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma","volume":"34","author":"Koens","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"2023012006304245700_b54-1390515","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.leukres.2011.06.004","article-title":"The expression of IgM is helpful in the differentiation of primary cutaneous diffuse large B cell lymphoma and follicle center lymphoma","volume":"35","author":"Demirkesen","year":"2011","journal-title":"Leuk Res"},{"key":"2023012006304245700_b55-1390515","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1200\/JCO.2005.02.0842","article-title":"Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma","volume":"24","author":"Dijkman","year":"2006","journal-title":"J Clin Oncol"},{"key":"2023012006304245700_b56-1390515","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1182\/blood-2005-08-3443","article-title":"Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID","volume":"107","author":"Dijkman","year":"2006","journal-title":"Blood"},{"key":"2023012006304245700_b57-1390515","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00428-008-0593-x","article-title":"Inactivation of p16INK4a\/CDKN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomas","volume":"452","author":"Belaud-Rotureau","year":"2008","journal-title":"Virchows Arch"},{"key":"2023012006304245700_b58-1390515","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1600-0625.2010.01226.x","article-title":"Simultaneous aberrations of single CDKN2A network components and a high Rb phosphorylation status can differentiate subgroups of primary cutaneous B-cell lymphomas","volume":"20","author":"Kaune","year":"2011","journal-title":"Exp Dermatol"},{"key":"2023012006304245700_b59-1390515","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.0303-6987.2003.00167.x","article-title":"Borrelia burgdorferi-associated lymphocytoma cutis: clinicopathologic, immunophenotypic, and molecular study of 106 cases","volume":"31","author":"Colli","year":"2004","journal-title":"J Cutan Pathol"},{"key":"2023012006304245700_b60-1390515","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/00000478-200312000-00006","article-title":"Primary cutaneous diffuse large B-cell lymphoma: prognostic significance of clinicopathological subtypes","volume":"27","author":"Goodlad","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"2023012006304245700_b61-1390515","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1200\/JCO.2001.19.16.3602","article-title":"Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study","volume":"19","author":"Grange","year":"2001","journal-title":"J Clin Oncol"},{"key":"2023012006304245700_b62-1390515","first-page":"242","article-title":"Primary cutaneous DLBCL, leg type","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Meijer","year":"2008"},{"key":"2023012006304245700_b63-1390515","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/DAD.0b013e3181eeb433","article-title":"The histomorphologic spectrum of primary cutaneous diffuse large B-cell lymphoma: a study of 79 cases","volume":"33","author":"Plaza","year":"2011","journal-title":"Am J Dermatopathol"},{"key":"2023012006304245700_b64-1390515","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jaad.2011.03.031","article-title":"Primary cutaneous diffuse large B-cell lymphoma, leg type and secondary cutaneous involvement by testicular B-cell lymphoma share identical clinicopathological and immunophenotypical features","volume":"66","author":"Muniesa","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"2023012006304245700_b65-1390515","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.2005.03.6285","article-title":"Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas","volume":"24","author":"Zinzani","year":"2006","journal-title":"J Clin Oncol"},{"key":"2023012006304245700_b66-1390515","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/modpathol.3800650","article-title":"Expression of B-cell transcription factors in primary cutaneous B-cell lymphoma","volume":"19","author":"Hoefnagel","year":"2006","journal-title":"Mod Pathol"},{"key":"2023012006304245700_b67-1390515","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood-2004-04-1594","article-title":"Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling","volume":"105","author":"Hoefnagel","year":"2004","journal-title":"Blood"},{"key":"2023012006304245700_b68-1390515","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.0022-202X.2004.22720.x","article-title":"Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas","volume":"123","author":"Hallermann","year":"2004","journal-title":"J Invest Dermatol"},{"key":"2023012006304245700_b69-1390515","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/01.pas.0000155163.40668.e7","article-title":"Genetic aberrations in primary cutaneous large B-cell lymphoma: a fluorescence in situ hybridization study of 25 cases","volume":"29","author":"Wiesner","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"2023012006304245700_b70-1390515","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/jid.2008.357","article-title":"Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"129","author":"Senff","year":"2009","journal-title":"J Invest Dermatol"},{"key":"2023012006304245700_b71-1390515","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1365-2141.2010.08354.x","article-title":"Molecular analysis of intravascular large B-cell lymphoma with neoangiogenesis","volume":"152","author":"Saurel","year":"2011","journal-title":"Br J Haematol"},{"key":"2023012006304245700_b72-1390515","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.2004.05177.x","article-title":"Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the \u2018cutaneous variant\u2019","volume":"127","author":"Ferreri","year":"2004","journal-title":"Br J Haematol"},{"key":"2023012006304245700_b73-1390515","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-0560.2010.01538.x","article-title":"Cutaneous intravascular anaplastic large cell lymphoma","volume":"38","author":"Wang","year":"2011","journal-title":"J Cutan Pathol"},{"key":"2023012006304245700_b74-1390515","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1600-0560.2010.01528.x","article-title":"ALK-negative systemic intravascular anaplastic large cell lymphoma presenting in the skin","volume":"38","author":"Rieger","year":"2011","journal-title":"J Cutan Pathol"},{"key":"2023012006304245700_b75-1390515","first-page":"351","article-title":"Intralymphatic histiocytosis following placement of a metal implant","volume":"38","author":"Grekin","year":"2011","journal-title":"J Cutan Pathol"},{"key":"2023012006304245700_b76-1390515","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/DAD.0b013e3181986cc2","article-title":"Intralymphatic histiocytosis: a clinicopathologic study of 16 cases","volume":"31","author":"Requena","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"2023012006304245700_b77-1390515","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/modpathol.3880250","article-title":"Primary cutaneous T-cell-rich B-cell lymphoma: clinically distinct from its nodal counterpart?","volume":"14","author":"Li","year":"2001","journal-title":"Mod Pathol"},{"key":"2023012006304245700_b78-1390515","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000077324","article-title":"Cutaneous plasmablastic lymphoma in an HIV-positive male: an unrecognized cutaneous manifestation","volume":"208","author":"Hausermann","year":"2004","journal-title":"Dermatology"},{"key":"2023012006304245700_b79-1390515","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1097\/00000478-200210000-00008","article-title":"Mantle cell lymphoma involving skin: cutaneous lesions may be the first manifestation of disease and tumors often have blastoid cytologic features","volume":"26","author":"Sen","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"2023012006304245700_b80-1390515","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.3109\/10428194.2011.618233","article-title":"Three cases of primary cutaneous lymphoblastic lymphoma: microarray-based comparative genomic hybridization and gene expression profiling studies with review of literature","volume":"53","author":"Vezzoli","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"2023012006304245700_b81-1390515","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1309\/AJCPFMNYCVPDEND0","article-title":"Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases","volume":"135","author":"Benet","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"2023012006304245700_b82-1390515","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","article-title":"EBV positive mucocutaneous ulcer: a study of 26 cases associated with various sources of immunosuppression","volume":"34","author":"Dojcinov","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"2023012006304245700_b83-1390515","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00428-011-1064-3","article-title":"Iatrogenic EBV-positive lymphoproliferative disorder with features of EBV+ mucocutaneous ulcer: evidence for concomitant TCRgamma\/IGH rearrangements in the Hodgkin-like neoplastic cells","volume":"458","author":"Di Napoli","year":"2011","journal-title":"Virchows Arch"},{"key":"2023012006304245700_b84-1390515","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1182\/blood-2010-12-323238","article-title":"Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma","volume":"117","author":"Dojcinov","year":"2011","journal-title":"Blood"},{"key":"2023012006304245700_b85-1390515","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000325460","article-title":"Oral eosinophilic ulcer, an Epstein-Barr virus-associated CD30+ lymphoproliferation?","volume":"222","author":"Abdel-Naser","year":"2011","journal-title":"Dermatology"},{"key":"2023012006304245700_b86-1390515","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1309\/AJCPX3S5MSOVVLOP","article-title":"T-cell receptor gene rearrangement and CD30 immunoreactivity in traumatic ulcerative granuloma with stromal eosinophilia of the oral cavity","volume":"132","author":"Salisbury","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"(suppl 1)","key":"2023012006304245700_b87-1390515","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/modpathol.2012.181","article-title":"Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfalls","volume":"26","author":"Jaffe","year":"2013","journal-title":"Mod Pathol"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/139\/4\/515\/48794980\/ajcp_139_4_515.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/139\/4\/515\/48794980\/ajcp_139_4_515.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T06:32:17Z","timestamp":1674196337000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/139\/4\/515\/1761016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,1]]},"references-count":87,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,1]]},"published-print":{"date-parts":[[2013,4,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcpnlc9nc9wtqyy","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2013,4,1]]},"published":{"date-parts":[[2013,4,1]]}}}